-
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) today welcomed a new £6 million investment by GSK plc (LSE/NYSE: GSK) and ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as ...
-
The Global Fund warmly welcomes Germany’s commitment of €1 billion to the Eighth Replenishment, announced at the World Health Summit in Berlin - a powerful signal of its enduring leadership in global health and its deep commitment to equity, resilien...
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), commends Denmark’s DKK 375 million pledge, which underscores its long-standing commitment to global health at a critical time of escalating health challenges and widening ineq...
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) warmly applauds Switzerland’s early pledge of CHF 64 million to the Eighth Replenishment.
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) commends Portugal’s early pledge of €1.5 million to the Eighth Replenishment. The pledge was announced today in New York on the margins of the UN General Assembly.
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) announced private sector pledges totaling more than US$1 billion over this last week, marking a major step forward in its Eighth Replenishment.